Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral

Table 1 Comparison of demographic and clinical data of patients

Parameters	Ishak 0-2 (n = 9)	Ishak 3-4 (n = 18)	Ishak 5-6 (n = 12)
Age (yr)	36.3 ± 15.5	37.9 ± 12.4	53.1 ± 11.0b
Male, n (%)	2 (22.2)	11 (61.1)	7 (58.3)
ALT (U/L)	44 (22.5)	52.5 (35.5)	75.5 (98.7)a
TB (μmol/L)	11 (7.5)	14 (3.5)	12.5 (7.5)
Alb (g/L)	46.78 ± 3.77	45.72 ± 3.75	44.17 ± 3.35
INR	0.99 ± 0.07	1.00 ± 0.09	1.09 ± 0.16
PLT (× 109/L)	171 (62.5)	177.5 (64.7)	114 (67.5)b
HCV RNA (log10 IU/mL)	6.43 ± 0.96	6.50 ± 0.71	6.33 ± 0.64
mHAI score	3.4 ± 1.7	5.3 ± 1.6a	11.3 ± 4.0c

^aP < 0.05 compared with patients with Ishak 0-2.

^bP < 0.01 compared with patients with Ishak 0-2.

^cP < 0.001 compared with patients with Ishak 0-2.

ALT: Alanine aminotransferase; TB: Total bilirubin; INR: International normalized ratio; HCV: Hepatitis C virus; mHAI: Modified histology activity index.